Curis
CRIS
#11081
Rank
ยฃ0.5 M
Marketcap
ยฃ0.26
Share price
-17.89%
Change (1 day)
-79.04%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of March 2026 : ยฃ0.99 Million

According to Curis's latest financial reports the company's total debt is ยฃ0.99 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ1.2 M-48.96%
2024-12-31ยฃ2.35 M7.33%
2023-12-31ยฃ2.19 M-32.68%
2022-12-31ยฃ3.25 M-12.75%
2021-12-31ยฃ3.73 M-33.58%
2020-12-31ยฃ5.62 M4340.38%
2019-12-31ยฃ0.12 M-99.55%
2018-12-31ยฃ27.95 M-9.08%
2017-12-31ยฃ30.74 M91.03%
2016-12-31ยฃ16.09 M-1.3%
2015-12-31ยฃ16.3 M-10.29%
2014-12-31ยฃ18.17 M-1.88%
2013-12-31ยฃ18.52 M0.34%
2012-12-31ยฃ18.46 M
2008-12-31N/A-100%
2007-12-31ยฃ0.2 M-79.89%
2006-12-31ยฃ1.01 M-70.12%
2005-12-31ยฃ3.38 M-5.24%
2004-12-31ยฃ3.56 M12.86%
2003-12-31ยฃ3.16 M-59.16%
2002-12-31ยฃ7.74 M6.23%
2001-12-31ยฃ7.28 M77.55%
2000-12-31ยฃ4.1 M388.9%
1999-12-31ยฃ0.83 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ47.27 B 4,766,541.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ34.43 B 3,472,450.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
ยฃ21.39 M 2,057.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.12 B 12,580.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ1.41 M 42.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
ยฃ6.31 M 536.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.42 B 42,802.02%๐Ÿ‡บ๐Ÿ‡ธ USA